Simplifying Global Compliance
FDA Proposes Collaborative Approach for Pediatric Rare Disease Research
Clinical Trials Advisor
For more efficient development of treatments for pediatric rare diseases, sponsors can implement controlled, multi-arm, multi-company clinical trials, according to a new draft guidance that the FDA says could help eliminate the need for certain studies.
To View This Article:
Subscribe To Clinical Trials Advisor
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing